These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11897832)

  • 1. Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
    Hamann U; Liu X; Lange S; Ulmer HU; Benner A; Scott RJ
    J Med Genet; 2002 Mar; 39(3):E12. PubMed ID: 11897832
    [No Abstract]   [Full Text] [Related]  

  • 2. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
    Ladopoulou A; Kroupis C; Konstantopoulou I; Ioannidou-Mouzaka L; Schofield AC; Pantazidis A; Armaou S; Tsiagas I; Lianidou E; Efstathiou E; Tsionou C; Panopoulos C; Mihalatos M; Nasioulas G; Skarlos D; Haites NE; Fountzilas G; Pandis N; Yannoukakos D
    Cancer Lett; 2002 Nov; 185(1):61-70. PubMed ID: 12142080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.
    Gayther SA; Russell P; Harrington P; Antoniou AC; Easton DF; Ponder BA
    Am J Hum Genet; 1999 Oct; 65(4):1021-9. PubMed ID: 10486320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
    Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
    J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
    Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
    Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
    Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.
    Kauff ND; Perez-Segura P; Robson ME; Scheuer L; Siegel B; Schluger A; Rapaport B; Frank TS; Nafa K; Ellis NA; Parmigiani G; Offit K
    J Med Genet; 2002 Aug; 39(8):611-4. PubMed ID: 12161607
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.
    Yassaee VR; Zeinali S; Harirchi I; Jarvandi S; Mohagheghi MA; Hornby DP; Dalton A
    Breast Cancer Res; 2002; 4(4):R6. PubMed ID: 12100744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula.
    Vega A; Torres M; Martínez JI; Ruiz-Ponte C; Barros F; Carracedo A
    Ann Hum Genet; 2002 Jan; 66(Pt 1):29-36. PubMed ID: 12014998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.
    Palmieri G; Palomba G; Cossu A; Pisano M; Dedola MF; Sarobba MG; Farris A; Olmeo N; Contu A; Pasca A; Satta MP; Persico I; Carboni AA; Cossu-Rocca P; Contini M; Mangion J; Stratton MR; Tanda F
    Ann Oncol; 2002 Dec; 13(12):1899-907. PubMed ID: 12453858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic.
    Foretova L; Machackova E; Navratilova M; Pavlu H; Hruba M; Lukesova M; Valik D
    Hum Mutat; 2004 Apr; 23(4):397-8. PubMed ID: 15024741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
    Edwards SM; Kote-Jarai Z; Meitz J; Hamoudi R; Hope Q; Osin P; Jackson R; Southgate C; Singh R; Falconer A; Dearnaley DP; Ardern-Jones A; Murkin A; Dowe A; Kelly J; Williams S; Oram R; Stevens M; Teare DM; Ponder BA; Gayther SA; Easton DF; Eeles RA; ;
    Am J Hum Genet; 2003 Jan; 72(1):1-12. PubMed ID: 12474142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
    Leegte B; van der Hout AH; Deffenbaugh AM; Bakker MK; Mulder IM; ten Berge A; Leenders EP; Wesseling J; de Hullu J; Hoogerbrugge N; Ligtenberg MJ; Ardern-Jones A; Bancroft E; Salmon A; Barwell J; Eeles R; Oosterwijk JC
    J Med Genet; 2005 Mar; 42(3):e20. PubMed ID: 15744030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.